Cita APA

Reiter, R. J., Cardinali, D. P., Neel, R. L., Domínguez Rodriguez, A., Brown, G. M., & Tesarik, J. (2021). Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2. Web

Citación estilo Chicago

Reiter, Russel J., Daniel Pedro Cardinali, Richard L. Neel, Alberto Domínguez Rodriguez, Gregory M. Brown, and Jan Tesarik. Rationale for the Continued Use of Melatonin to Combat the Delta Variant of SARS-CoV-2. 2021.

Cita MLA

Reiter, Russel J., et al. Rationale for the Continued Use of Melatonin to Combat the Delta Variant of SARS-CoV-2. 2021.